Group One Trading’s Zura Bio ZURA Stock Holding History

Group One Trading’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$505K	Buy	84,865 +84,665	+42,333%	+$511K	﹤0.01%	3338
2025 Q4	$1.05K	Buy	+200	New	+$791	﹤0.01%	7700

Other funds holding ZURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Group One Trading's ZURA Position: Q1 2026 in Review

Group One Trading increased its Zura Bio (ZURA) stake by 42,333% in Q1 2026, buying an estimated $511K and bringing the position to 84,865 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #3338.

Group One Trading first reported a position in ZURA in Q4 2025 and has held it in 2 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

Group One Trading held 84,865 shares of Zura Bio worth $505K as of Q1 2026.
Group One Trading bought 84,665 Zura Bio shares in Q1 2026, an estimated $511K.
Zura Bio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3338 holding.
Group One Trading first reported a position in Zura Bio in Q4 2025 and has held it in 2 quarters since.
94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.